CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...